We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+4.81%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$86.8M
AUM Growth
-$18.6M
Cap. Flow
-$21.3M
Cap. Flow %
-24.54%
Top 10 Hldgs %
34.84%
Holding
103
New
20
Increased
22
Reduced
25
Closed
29

Top Buys

Rank Stock Value
1
ALNA
Allena Pharmaceuticals
ALNA
+$7.09M
2
BIDU icon
Baidu
BIDU
+$2.46M
3
ZBH icon
Zimmer Biomet
ZBH
+$1.67M
4
CME icon
CME Group
CME
+$1.46M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.44M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$2.37M
2
JD icon
JD.com
JD
+$1.84M
3
ELV icon
Elevance Health
ELV
+$1.77M
4
AGN.PRA
Allergan plc
AGN.PRA
+$1.76M
5
CNC icon
Centene
CNC
+$1.61M

Sector Composition

Rank Sector Weight
1 Healthcare 49.46%
2 Technology 16.05%
3 Communication Services 4.89%
4 Financials 3.92%
5 Consumer Discretionary 3.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CI icon
26
Cigna
CI
$73.7B
$1.28M 1.48%
6,307
-3,159
-33% -$629K
ELV icon
27
Elevance Health
ELV
$81.5B
$1.28M 1.47%
5,689
-8,315
-59% -$1.77M
ZAYO
28
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$1.26M 1.45%
34,190
-13,355
-28% -$472K
JUNO
29
DELISTED
Juno Therapeutics, Inc.
JUNO
$1.19M 1.37%
26,066
+6,258
+32% +$312K
ZEN
30
DELISTED
ZENDESK INC
ZEN
$1.19M 1.37%
35,126
+11,803
+51% +$386K
DXC icon
31
DXC Technology
DXC
$1.82B
$1.17M 1.34%
14,199
+1,503
+12% +$121K
GOOGL icon
32
Alphabet (Google) Class A
GOOGL
$4.36T
$1.16M 1.33%
21,940
-18,460
-46% -$953K
ACOR
33
DELISTED
Acorda Therapeutics
ACOR
$1.15M 1.32%
445
-54
-11% -$154K
ATVI
34
DELISTED
Activision Blizzard
ATVI
$1.14M 1.31%
17,981
-7,875
-30% -$498K
HOLX
35
DELISTED
Hologic
HOLX
$1.14M 1.31%
+26,578
New +$1.06M
PEN icon
36
Penumbra
PEN
$12.7B
$1.03M 1.19%
10,971
+1,368
+14% +$136K
RVTY icon
37
Revvity
RVTY
$12.6B
$1.02M 1.18%
14,007
+1,809
+15% +$130K
AMZN icon
38
Amazon
AMZN
$2.92T
$934K 1.08%
15,980
-28,120
-64% -$1.55M
MDCO
39
DELISTED
Medicines Co
MDCO
$920K 1.06%
33,661
+4,222
+14% +$130K
UHS icon
40
Universal Health Services
UHS
$10.2B
$801K 0.92%
+7,071
New +$756K
ESPR
41
DELISTED
Esperion Therapeutics
ESPR
$799K 0.92%
12,140
+3,021
+33% +$163K
MYOK
42
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$779K 0.9%
18,501
-4,236
-19% -$163K
BPMC
43
DELISTED
Blueprint Medicines
BPMC
$756K 0.87%
10,020
-11,232
-53% -$790K
NFLX icon
44
Netflix
NFLX
$299B
$737K 0.85%
38,370
-25,460
-40% -$490K
NVDA icon
45
NVIDIA
NVDA
$4.86T
$734K 0.85%
151,760
+34,960
+30% +$174K
MSFT icon
46
Microsoft
MSFT
$3.45T
$707K 0.81%
8,269
-16,087
-66% -$1.32M
TSLA icon
47
Tesla
TSLA
$1.23T
$673K 0.78%
+32,400
New +$705K
XYZ
48
Block Inc
XYZ
$48.4B
$656K 0.76%
18,922
+2,446
+15% +$89.6K
MMSI icon
49
Merit Medical Systems
MMSI
$5.08B
$611K 0.7%
14,146
+3,466
+32% +$145K
HRC
50
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$597K 0.69%
7,086
+1,730
+32% +$140K
1
2
3 4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, Partner Investment Management held 103 positions worth $86.8M, down 18% from $105M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Partner Investment Management withdrew a net $21.3M in Q4 2017, closing 29 positions and reducing 25 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $2.37M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, up from 34% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Partner Investment Management opened a new position in Allena Pharmaceuticals worth $4.72M.

  • Partner Investment Management's largest Q4 2017 buy was Allena Pharmaceuticals: 575,407 shares worth $4.72M.
  • Partner Investment Management added most to Puma Biotechnology in Q4 2017, an estimated $568K increase.
  • Partner Investment Management's biggest Q4 2017 reduction was Elevance Health, cutting an estimated $1.77M.
  • Partner Investment Management fully exited Meta Platforms (Facebook) in Q4 2017, selling an estimated $2.37M.
  • Partner Investment Management's ten largest holdings make up 35% of its $86.8M portfolio in Q4 2017.
  • Partner Investment Management opened 20 new positions and closed 29 in Q4 2017.
  • Partner Investment Management's portfolio value fell 18% quarter-over-quarter to $86.8M.

Based on Partner Investment Management's 13F filing for Q4 2017, filed 14 Feb 2018.